Figure 1.
Extracellular vesicles (EVs) based therapeutic platforms: intrinsic natural properties allow EV to be easily harnessed from different biological fluids and adopted for monitoring the patient treatment response (EVs-based biomarker platform). Moreover, the mirror properties of EVs has been harnessed to develop EVs-based therapeutic platform which includes mesenchimal stem cells derived EVs, mostly applied in the area of regenerative medicine, and dendritic cells derived EVs for immunotherapeutic application. The majority of EVs finds application as carrier for different drugs including small synthetic molecules, natural products and oligonucleotide therapeutics (EVs-based drugs delivery platform)